Reuters -- Hospira Inc, a maker of hospital products, medical devices and injectable drugs, said on Friday it had received a warning letter from the U.S. Food and Drug Administration after an inspection of two manufacturing plants in North Carolina.
Reuters -- Hospira Inc, a maker of hospital products, medical devices and injectable drugs, said on Friday it had received a warning letter from the U.S. Food and Drug Administration after an inspection of two manufacturing plants in North Carolina.
